Hybrid oligonucleotides: Synthesis, biophysical properties, stability studies, and biological activity

Bioorganic and Medicinal Chemistry

Volumn 4, Issue 10, 1996, Pages 1685-1692

  Yu, Dong ^a   Iyer, Radhakrishnan P ^a   Shaw, Denise R ^b   Lisziewicz, Julianna ^c   Li, Ying ^a   Jiang, Zhiwei ^a   Roskey, Allysen ^a   Agrawal, Sudhir ^a  

^a HYBRIDON INC   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; OLIGONUCLEOTIDE;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; DENATURATION; DRUG ACTIVITY; DRUG STABILITY; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030272272     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/0968-0896(96)00160-5     Document Type: Article

References (35)

1. 1. Uhlmann, E.; Peyman, A. Chem. Rev. 1990, 90, 544.
2. 2. Agrawal, S.; Iyer, R. P. Curr. Op. Biotech. 1995, 6, 12.
3. 3. Zon, G. Pharm. Rev. 1988, 5, 539.
4. 4. Agrawal, S.; Temsamani, J.; Galbraith, W.; Tang, J.-Y. Clin. Pharmacokinet. 1995, 28, 7.
5. 5. Crooke, R. M. Anti-cancer Drug Des. 1991, 6, 609.
6. 6. Sands, H.; Gorey-Feret, L. J.; Cocuzza, A. J.; Hobbs, F. W.; Chidester, D.; Trainor, G. L. Mol. Pharmacol. 1994, 45, 932.
7. 7. Iversen, P. L.; Mata, J.; Tracewell, W. G.; Zon, G. Antisense Res. Dev. 1994, 4, 43.
8. 8. Cossum, P. A.; Sasmor, H.; Dellinger, D.; Truong, L.; Cummins, L.; Owens, S. R.; Markham, P. M.; Shea, J. P.; Crooke, S. T. J. Pharmacol. Exp. Ther. 1993, 267, 1181.
9. 9. Cossum, P. A.; Truong, L.; Owens, S. R.; Markham, P. M.; Shea, J. P.; Crooke, S. T. J. Pharmacol. Exp. Ther. 1994, 269, 89.
10. 10. Zhang, R.; Diasio, R. B.; Lu, T. P.; Jiang, Z.; Galbraith, W. M.; Agrawal, S. Biochem. Pharmacol. 1994, 49, 929.
11. 11. Galbraith, W. M.; Hobson, W. C.; Giclas, P. C.; Schechter, P. J.; Agrawal, S. Antisense Res. Dev. 1994, 4, 201.
12. 12. Cornish, K. G.; Iversen, P.; Smith, L.; Arneson, M.; Bayever, E. Pharmacol. Commun. 1993, 3, 239.
13. 13. Metelev, V.; Agrawal S. Proc. Int. Conf. Nucleic acid. 1993, Cancun, 1(1).
14. 14. Metelev, V.; Lisziewicz, J.; Agrawal, S. Bioorg. Med. Chem. Lett. 1994, 4, 2929.
15. 15. Mayer, M. M. In Experimental Immunochemistry; Kabat, E. A.; Mayer, M. M., Eds.; C. C. Thomas: Springfield, 1961; pp 125-131.
16. 16. (a) Shibahara, S.; Mukai, S.; Nishihara, T.; Inoue, H.; Ohtsuka, E.; Morisawa, H. Nucl. Acids Res. 1987, 15, 4403;
17. (b) Monia, B. P.; Lesnik, E. A.; Gonzalez, C.; Lima, W. F.; McGee, D.; Guinosso, C. J.; Kawasaki, A. M.; Cook, P. D.; Freier, S. M. J. Biol. Chem. 1993, 268, 14514.
18. 17. Furdon, P. S.; Dominski, Z.; Kole, R. Nucl. Acids Res. 1989, 17, 9193.
19. 18. (a) Giles, R. V.; Spiller, D. G.; Tidd, D. M. Anticancer Drug Des. 1993, 8, 33;
20. (b) Iyer, R. P.; Uznanski, B.; Boal, J.; Storm, C.; Egan, W.; Matsukura, M.; Broder, S.; Zon, G.; Wilk, A.; Koziolkiewicz, M.; Stec, W. J. Nucl. Acids Res. 1990, 18, 2855;
21. (c) Gao, W.; Stein, C. A.; Cohen, J. S.; Dutschman, G. E.; Cheng, Y.-C. J. Biol. Chem. 1989, 264, 11521.
22. 19. Lisziewicz, J.; Sun D.; Metelev, V.; Zamecnik, P. C.; Gallo, R. C.; Agrawal, S. Proc. Natl. Acad. Sci. U.S.A . 1993, 90, 3860.
23. 20. Zhang, R.; Yan, T.; Shahinian, H.; Amin, G.; Lu, Z.; Liu, T.; Saag, M. S.; Jiang, Z.; Temsamani, J.; Martin, R. R.; Schechter, P. S.; Agrawal, S.; Diasio, R. B. Clin. Pharm. Therap. 1995, 58, 44.
24. 21. Sereni, D.; Katlama, C.; Gouyette, A.; Re, M.; Lascoux, C.; Tubiana, R.; Tournerie, C. 34th Interscience Conference on Antimicrobial Chemotherapy, ICAACC, 6, M10.
25. 22. Bayever, E.; Iversen, P. L.; Bishop, M. R.; Sharp, G. J.; Tewary, H. K.; Arneson, M. A.; Pirruccello, S. J.; Ruddon, R. W.; Kessinger, A.; Zon, G.; Armitage, J. O. Antisense Res. Dev. 1993, 3, 383.
26. 23. Crooke, S. T.; Grillone, L. R.; Tendulkar, A.; Garrett, A.; Fraktin, M. J.; Leeds, J.; Barr, W. H. Clin. Pharm. Therap. 1994, 56, 641.
27. 24. (a) Iyer, R. P.; Yu, D.; Agrawal, S. Bioorg. Chem. 1995, 23, 1;
28. (b) Iyer, R. P.; Yu, D.; Ho, N.-H.; Agrawal, S. Synth. Commun. 1995, 25, 2739;
29. (c) Agrawal S. and Zhang, R. unpublished observations.
30. 25. Padmapriya, A.; Tang, J.-Y.; Agrawal, S. Antisense Res. Dev. 1994, 4, 185.
31. 26. Iyer, R. P.; Jiang, Z.; Yu, D., Agrawal, S. Nucleosides Nucleotides 1995, 14, 1349.
32. 27. Beaucage, S. L. In Protocols for Oligonucleotides and Analogs; Agrawal, S., Ed.; Humana: Totowa, 1993; Vol 20, p 33.
33. 28. Iyer, R. P.; Egan, W.; Regan, J. B.; Beaucage, S. L. J. Am. Chem. Soc. 1990, 112, 1253.
34. 29. Tang, J.-Y.; Temsamani, J.; Agrawal, S. Nucl. Acids Res. 1993, 21, 2729.
35. 30. Agrawal, S.; Lisziewicz, J. J. Biotech. Healthcare 1994, 1, 167, and therein.